Colorado 2024 Regular Session

Colorado Senate Bill SB077

Introduced
1/22/24  
Introduced
1/22/24  
Failed
3/7/24  
Refer
1/22/24  

Caption

Prescription Drug Manufacturer Requirements

Impact

The implementation of SB 077 is expected to significantly influence the operations of prescription drug manufacturers within Colorado. By incorporating a structured registration and reporting system, the state aims to foster greater transparency and accountability among these manufacturers. Additionally, the requirement to maintain copayment assistance programs could lead to improved access to medications for patients, ultimately enhancing healthcare outcomes in the state. Should manufacturers fail to comply with these requirements, they could face regulatory actions for engaging in deceptive practices, thus aiming to deter any potential violations.

Summary

Senate Bill 077 introduces new requirements for prescription drug manufacturers operating in Colorado. Specifically, it mandates that these manufacturers register with the Division of Insurance and pay a related fee. The bill also requires manufacturers to establish copayment assistance programs for covered individuals, ensuring that these programs remain available for the entire duration of the individual's enrollment in their health benefit plan. This initiative seeks to reduce the financial burden on patients with high out-of-pocket expenses tied to prescription medications.

Contention

Reactions to SB 077 have been mixed among stakeholders. Advocates for consumer rights and healthcare accessibility laud the measure, arguing it will provide essential support to patients struggling with the costs of medications. However, some pharmaceutical companies express concerns that the added bureaucratic requirements could stifle innovation and increase the financial burden on manufacturers. Legislators will need to navigate these competing interests as they consider the bill's potential impact on healthcare affordability and the pharmaceutical industry in Colorado.

Companion Bills

No companion bills found.

Previously Filed As

CO HB3086

Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.

CO SB00494

An Act Concerning Prescription Drug Shortages, Prescription Drug Rebates And Prohibited Manufacturer Practices Concerning Certain Prescription Drugs.

CO SB1094

An act to amend Section 4073.5 of the Business and Professions Code, to amend Section 1367.22 of the Health and Safety Code, and to add Section 10123.190 to the Insurance Code, relating to prescription drugs.

CO SF3650

Manufacturers prohibited from advertising prescription drugs on television

CO HF4124

Manufacturers prohibited from advertising prescription drugs on television.

CO SB289

Relating to prescription drugs.

CO LD1053

An Act to Ensure That Rebates from Prescription Drug Manufacturers Are Passed on to Patients at Pharmacies

CO SB1149

Prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE)

CO AB1170

Prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE)

CO SB2283

Relating To Prescription Drugs.

Similar Bills

MI HB5941

House Bill 5941 of 2026

MS SB2715

Pharmaceuticals; authorize the Division of Medicaid to establish a wholesale prescription drug importation program.

FL S1418

Testing of Cosmetics on Animals

OR HB3082

Relating to reporting obligations for patient assistance programs for prescription drug purchases.

FL H1333

Testing of Cosmetics on Animals

OR SB1528

Relating to health care.

OR SB289

Relating to prescription drugs.

NC H624

Prescription Drug Pricing